Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.75 USD | -0.05% | +3.11% | -18.63% |
04/06 | Bristol-Myers Squibb Says Opdivo Plus Yervoy Therapy Improves Survival of Liver Cancer Patients | MT |
04/06 | Bristol Myers: positive results in liver cancer | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.63% | 8.47TCr | |
+42.83% | 75TCr | |
+34.11% | 60TCr | |
-5.70% | 36TCr | |
+18.06% | 33TCr | |
+4.63% | 28TCr | |
+17.02% | 24TCr | |
+9.26% | 21TCr | |
-4.21% | 21TCr | |
+2.43% | 17TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11